SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001393905-21-000005
Filing Date
2021-01-08
Accepted
2021-01-08 14:06:21
Documents
3
Period of Report
2020-11-12
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 rtsl_8ka.htm 8-K/A 20788
2 AUDITED FINANCIAL STATEMENTS rtsl_ex991.htm EX-99.1 76962
3 UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS rtsl_ex992.htm EX-99.2 106944
  Complete submission text file 0001393905-21-000005.txt   205979
Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240
Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

IRS No.: 462111820 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K/A | Act: 34 | File No.: 000-55018 | Film No.: 21516957
SIC: 2834 Pharmaceutical Preparations